Trial Profile
A study evaluating effect of rotigotine and levodoapa on biomarkers for oxidative stress in Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2017
Price :
$35
*
At a glance
- Drugs Levodopa (Primary) ; Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- 15 May 2017 New trial record
- 01 May 2017 Results published in the Neurological Research